Agency Information Collection Activities; Proposed eCollection, eComments Requested; Reinstatement Without Change of a Previously Approved Collection; U.S. Official Order Forms for Schedules I and II Controlled Substances; DEA Form 222

Issuing agencies

Abstract

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register, at 91 FR 46483, on July 23, 2026, allowing a 60- day comment period.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 189 (Thursday, October 1, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 189 (Thursday, October 1, 2026)]
[Notices]
[Pages 62561-62562]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-20113]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0010]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Reinstatement Without Change of a Previously 
Approved Collection; U.S. Official Order Forms for Schedules I and II 
Controlled Substances; DEA Form 222

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995. The proposed information collection was previously published in 
the Federal Register, at 91 FR 46483, on July 23, 2026, allowing a 60-
day comment period.

DATES: Comments are encouraged and will be accepted for 30 days until 
November 2, 2026.

FOR FURTHER INFORMATION CONTACT: If you have comments especially on the 
estimated public burden or associated response time, suggestions, or 
need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Heather E. 
Achbach, Regulatory Drafting and Policy Support Section, Drug 
Enforcement Administration; Mailing Address: 8701 Morrissette Drive, 
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email: 
<a href="/cdn-cgi/l/email-protection#f0b4b5b1dea0a2b1b0949591de979f86"><span class="__cf_email__" data-cfemail="1f5b5a5e314f4d5e5f7b7a7e31787069">[email&#160;protected]</span></a> or <a href="/cdn-cgi/l/email-protection#743c1115001c11065a315a35171c1615171c341011155a131b02"><span class="__cf_email__" data-cfemail="21694440554944530f640f60424943404249614544400f464e57">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other forms of information technology, e.g.,

[[Page 62562]]

permitting electronic submission of responses.

    Written comments and recommendations for this information 
collection should be submitted within 30 days of the publication of 
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. 
Find this particular information collection by selecting ``Currently 
under 30-day Review--Open for Public Comments'' or by using the search 
function and entering either the title of the information collection or 
the OMB Control Number 1117-0010. This information collection request 
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view 
Department of Justice, information collections currently under review 
by OMB. If you submit a comment, please send a copy to Heather Achbach 
at <a href="/cdn-cgi/l/email-protection#d6929397f886849796b2b3b7f8b1b9a0"><span class="__cf_email__" data-cfemail="3f7b7a7e116f6d7e7f5b5a5e11585049">[email&#160;protected]</span></a>.
    DOJ seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. DOJ notes that information collection 
requirements submitted to the OMB for existing ICRs receive a month-to-
month extension while they undergo review.
    Abstract: The Controlled Substances Act (CSA) (21 U.S.C. 801-971) 
establishes a closed system of distribution for controlled substances. 
One tool that helps to maintain the closed system of distribution is 
the CSA provision that states it ``shall be unlawful for any person to 
distribute a controlled substance in schedules I or II to another 
except in pursuance of a written order of the person to whom such 
substance is distributed, made on a form to be issued by the Attorney 
General in blank in accordance with subsection (d) of this section.'' 
21 U.S.C. 828(a).

Overview of This Information Collection

    1. Type of Information Collection: Reinstatement of a previously 
approved collection.
    2. Title of the Form/Collection: U.S. Official Order Forms for 
Schedules I and II Controlled Substances.
    3. Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: DEA Form: 222. The 
applicable component within the Department of Justice is the Drug 
Enforcement Administration Office of Diversion Control.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract: Affected Public: (Primary): Businesses or 
other for-profit and not-for-profit institutions; Federal, State, 
local, and tribal governments.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 114,989 registrants participate in this information collection. 
The time per response is 6.19 minutes for the DEA-222.
    6. Estimated Time per Respondent: DEA estimates that this 
collection takes 1,624,529 annual burden hours.
    7. Frequency: As needed, 136.90191/annual.
    8. Total Estimated Annual Time Burden: 1,624,529 annual burden 
hours.
    9. Total Estimated Annual Other Costs Burden: $0.

                                               Total Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                       Time per
                Activity                    Number of     Frequency    Total annual    response    Total annual
                                           respondents                   responses      (hours)   burden (hours)
----------------------------------------------------------------------------------------------------------------
DEA-222 (paper).........................       114,989   2.916644201         335,382        0.25          83,846
DEA-222/CSOS (online)...................                    133.9853      15,406,832         0.1       1,539,846
                                         -----------------------------------------------------------------------
    Unduplicated Totals.................       114,989     136.90191      15,742,214   0.1031957       1,624,529
----------------------------------------------------------------------------------------------------------------

    If additional information is required, contact: Darwin Arceo, 
Department Clearance Officer, Enterprise Portfolio Management, Justice 
Management Division, United States Department of Justice, Two 
Constitution Square, 145 N Street NE, 4W-218, Washington, DC 20530.

    Dated: September 29, 2026.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2026-20113 Filed 9-30-26; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>